The head of the Chinese Academy of Sciences Interdisciplinary Research Center on Biology and Chemistry (Beijing, China), Junying Yuan, has received an Agilent Thought Leader Award. Agilent Technologies (California, USA) has given the award in recognition of Yuan?s scientific contributions to cellular biology and the understanding of neurodegenerative diseases.
The head of the Chinese Academy of Sciences Interdisciplinary Research Center on Biology and Chemistry (Beijing, China), Junying Yuan, has received an Agilent Thought Leader Award. Agilent Technologies (California, USA) has given the award in recognition of Yuan’s scientific contributions to cellular biology and the understanding of neurodegenerative diseases.
Agilent Technologies will support Yuan in her research into analyzing the proteins involved in neurodegenerative disease by supplying instruments. According to Yuan, her team plan to integrate metabolomics with transcriptomic and proteomic data to identify five to 10 new protein or biomarkers for neurodegenerative diseases within the next three years.
"Researchers using an integrated approach to the study of biology are gaining significant insights into the complex interactions between genes, proteins, and metabolites, which are accelerating the discovery of new therapies to treat serious neurodegenerative disorders such as Alzheimer's and Parkinson's disease," said Patrick Kaltenbach, Agilent's vice president and general manager of the LC–MS business. "We are honoured to support Dr Yuan and the Chinese Academy of Sciences in their pioneering research in this area."
Yuan also holds a professorship in cell biology at Harvard University and has published more than 160 peer-reviewed journal articles. Her research has received the National Institutes of Health Director's Pioneer Award and the Innovator's Award for Breast Cancer Research.
For more information please visit: www.agilent.com
LC–MS/MS Quantification of Plasma Proteins in Elephant Seals to Advance Wildlife Conservation
November 12th 2024Liquid chromatography and tandem mass spectrometry (LC–MS/MS) was used to show that repeated stress can cause delayed but sustained changes in blood plasma proteins associated with water conservation, immune responses, fat metabolism, insulin sensitivity, iron recycling, and hormone transport in elephant seals. Some of these changes may be novel markers of recent and chronic stress exposure in marine mammals.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.